In this CME-certified, on-demand Webcast of a CCO symposium at SNO 2019, a panel of expert faculty reviews and discusses the latest data on the use of tyrosine kinase inhibitors for the treatment of glioblastoma.
In this downloadable slideset, Rimas V. Lukas, MD, spotlights NTRK fusions and TRK-targeted therapies for patients with GBM.
In this downloadable slideset, Manmeet S. Ahluwalia, MD, FACP, highlights regorafenib in the REGOMA trial and other multiple receptor kinase inhibitors for patients with GBM.
In this downloadable slideset, Tom Mikkelsen, MD, FRCPC, examines optimal clinical trial approaches for GBM therapies.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.